Clinical Trials Logo

Clinical Trial Summary

Suicidal behavior (SB) is a public health problem. The clinical model currently admitted to the understanding of SB is a stress vulnerability model, but so far, all scientific works has no clinical application. The management of psychiatric patients, including depressed subjects, faces the inability to detect those with a high risk of SB. Many studies have shown a link between low cholesterol and SB. A study has recently proposed a total cholesterol threshold below which the risk of suicide could be increased. However, a prospective study is needed to assess the predictive nature of such an indicator.


Clinical Trial Description

Investigators propose to assess, within a cohort of patients, the predictive value of a total cholesterol threshold in the occurrence of SB.

555 inpatients suffering from a current Major depressive disorder (MDD), hospitalized in the Department of Emergency Psychiatry and Post Acute Care will be recruited.

Each patient will attend a total of 5 visits during a follow-up period of 18 months (visits at 1, 3, 6, 12, and 18 months) ;


Study Design

Intervention Model: Single Group Assignment, Masking: Open Label


Related Conditions & MeSH terms


NCT number NCT02847741
Study type Interventional
Source University Hospital, Montpellier
Contact
Status Active, not recruiting
Phase N/A
Start date June 2012
Completion date April 2017

See also
  Status Clinical Trial Phase
Completed NCT00071123 - Evaluating Brain Responses to Facial Expressions in Major Depressive Disorder N/A
Terminated NCT03327974 - Evolution of Dark Ideas When Introducing or Switching an Antidepressant N/A